Business and Finance

Mar 30th, 2021

Ajinomoto Co., Inc. to Establish a Dedicated Organization for Creating Businesses That Target Gen-Z – Co-Creation of Value with Startups and Universities
Mar 26th, 2021

Ajinomoto Co., Inc. and Bright Peak Therapeutics Inc. Enter into a Research Collaboration and License Agreement to Create Novel Immunocytokines
Feb 26th, 2021

Ajinomoto Co., Inc. Plans to Sell Its Entire Equity Stake in a Feed-use Amino Acid Company in Europe – Structural Reform of Animal Nutrition Business to be Completed to Accelerate Asset-Light Management
Jan 29th, 2021

Revision to Consolidated Performance Forecast of Ajinomoto Co., Inc. for Fiscal 2020
Dec 21st, 2020

Ajinomoto Co., Inc. Makes a Supplements Company in Ireland a Wholly Owned Subsidiary – Entering Europe’s Oral Nutritional Supplements Market
Dec 16th, 2020

Ajinomoto Co., Inc. Establishes a Corporate Venture Capital Arm – Driving Business Model Transformation for Value Creation in the Provision of Solutions for Food and Health Issues
Dec 15th, 2020

The Ajinomoto Group Enters into its First ESG Finance Agreement in Malaysia – AJINOMOTO (MALAYSIA) BERHAD Carries Out Capital Procurement Through “Sustainability-Linked Finance”
Nov 30th, 2020

Ajinomoto Co., Inc. Launches Industrial-use Stevia Sweetener AJISWEET™ RA – Providing “Stress-Free, Delicious Sweetness” for more people
Nov 17th, 2020

Ajinomoto Co., Inc. Wins Patent Infringement Suit Regarding Its Manufacturing Process for Monosodium Glutamate (MSG) Products in the Tokyo District Court
Nov 5th, 2020

Ajinomoto Co., Inc. Invests in Funds of U.S. Food Tech Venture Capital Firm AgFunder Inc. and Nippon Venture Capital Co. Ltd. of Japan